Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering

Neutral

AI Analysis

Summary

Jupiter Neurosciences announced pricing of a $2.0 million registered direct offering of 307,692 shares of common stock. The clinical-stage biopharmaceutical company focuses on central nervous system disorders and neuroinflammation.

Importance:3/10

Sentiment:

0.00

capital_raiseregistered_direct_offeringclinical_stageCNS_disorders

Related Companies

$JUNS

Read the original article

Published by GlobeNewswire Pharma on August 21, 2026 4:20 PM

Read Original